Burden, A David

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity

Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics

Psoriasis: Treatment and PathogenesisGenetic Associations and Epidemiology

Cited by 1,024

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis

Bachelez, H., Choon, S.-E., Marrakchi, S., Burden, A. D., Tsai, T.-F., Morita, A., Turki, H., Hall, D. B., Shear, M., Baum, P., et al. (2019) · New England Journal of Medicine

Psoriasis: Treatment and PathogenesisDermatology and Skin Diseases

Cited by 292

Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease: Table 1

Wolf, N., Quaranta, M., Prescott, N. J., Allen, M., Smith, R., Burden, A. D., Worthington, J., Griffiths, C. E. M., Mathew, C. G., Barker, J. N., et al. (2008) · Journal of Medical Genetics

Psoriasis: Treatment and PathogenesisGenetic Associations and Epidemiology

Cited by 171